About Us
Aqualung Therapeutics leadership are experienced academic leaders and scientists who have driven NAMPT as a druggable target.
THE TEAM
Joe "Skip" G.N. Garcia, MD
Founder and Chief Executive Officer
skip@aqualungtherapeutics.com
Currently the University of Arizona endowed Merlin K. DuVal MD Professor of Medicine and an elected member of the Institute of Medicine of the National Academies, Dr. Garcia is a physican-scientist with over 30 yrs of research experience in pulmonary disease.
Mike Jonen, Executive MBA
Chief Finance Officer
mike@aqualungtherapeutics.com
Over 20 years of business and high-level academic health sciences administrative experience.
Eddie T. Chiang, MA
Chief Operating Officer
eddie@aqualungtherapeutics.com
Expertise in vascular biology research and over 15 years in the Garcia research group.
Sara M. Camp, BA
Chief Research Officer
sara@aqualungtherapeutics.com
Specializes in the genomic and proteomic studies of lung injury with over 15 years experience with the Garcia research group.
THE SCIENTIFIC ADVISORY BOARD
Robert Schleimer, PhD
Chief, Allergy & Immunology
Professor of Medicine
Feinberg Northwestern University School of Medicine
Augustine Choi, MD
Dean and Provost for Medical Affairs
Professor of Medicine & Genetic Medicine
Weill Cornell Medical College
Jesse Hall, MD
Former Chief, Pulmonary & Critical Care Medicine
Professor of Medicine
University of Chicago School of Medicine